GS 3: EconomyGS 2: GovernancePrelims
GST 2.0: Re-labelling of drugs, medical devices not mandatory for stocks issued before Sept 22 (Must issue revised price lists to dealers, retailers for display), Pg 15.
GST 2.0: Drug re-labeling not mandatory; individual insurance exempted; 18% GST on e-commerce delivery charges imposed.